Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. Launching in 2013, the new HGT Clinical Development, a quarterly journal, will serve as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products. For more information visit www.liebertpub.com/hum.
©2013, Mary Ann Liebert, Inc., publishers